Cas No.: | 1805789-54-1 |
Chemical Name: | Samuraciclib hydrochloride |
Synonyms: | Samuraciclib hydrochloride;ICEC0942 HCl;YOH5NJ0DC3;Samuraciclib (hydrochloride);CT7001 hydrochloride;(3R,4R)-4-(((7-(Benzylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-5-yl)amino)methyl)piperidin-3-ol hydrochloride;ICEC0942 (CT7001);ICEC0942 hydrochloride;S8722;3-Piperidinol, 4-(((3-(1-methylethyl)-7-((phenylmethyl)amino)pyrazolo(1,5-a)pyrimidin-5-yl)amino)methyl)-, hydro |
SMILES: | Cl.O[C@H]1CNCC[C@@H]1CNC1C=C(NCC2C=CC=CC=2)N2C(=C(C=N2)C(C)C)N=1 |
Formula: | C22H31ClN6O |
M.Wt: | 430.974143266678 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | CT7001 hydrochloride is a selective CDK7 inhibitor, with IC50s of 41 nM and 578 nM for CDK7/CycH/MAT1 and CDK2/cycE1, respectively. |
In Vitro: | CT7001 (ICEC0942) is a selective CDK7 inhibitor, with IC50s of 41 nM and 578 nM for CDK7/CycH/MAT1 and CDK2/cycE1, respectively[1]. |